Search Result "maraviroc"
Long-Term Immunovirogical Effect and Tolerability of a Maraviroc- Containing Regimen in Routine Clinical Practice
Journal: Current HIV Research
Volume: 8 Issue: 6 Year: 2010 Page: 482-486
Author(s): Miguel Genebat, Ezequiel Ruiz-Mateos, Ildefonso Pulido, Alejandro Gonzalez-Serna, Antonio Garcia-Perganeda, Gema Mendez, Maria Concepcion Romero-Sanchez, Sara Ferrando-Martinez, Manuel Leal
Overcoming hERG Affinity in the Discovery of Maraviroc; A CCR5 Antagonist for the Treatment of HIV
Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 1140-1151
Author(s): David A. Price, Duncan Armour, Marcel de Groot, Derek Leishman, Carolyn Napier, Manos Perros, Blanda L. Stammen, Anthony Wood
Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2014 Page: 1504-1514
Author(s): Guoyan G. Xu, Jia Guo, Yuntao Wu
Maraviroc Oral Disintegration Tablet: Analytical Design of Experiments(DoE) for Assessment and Comparison of In vitro Dissolution Profiles
Journal: Current Pharmaceutical Analysis
Volume: 18 Issue: 4 Year: 2022 Page: 427-436
Author(s): Akula Ramesh,Jagadish Purale Channabasavaish,Vinay Jhawar,Proneel Das,Prajakta Patil,Srinivas Mutalik
Coreceptor Tropism and Maraviroc Sensitivity of Clonally Derived Ethiopian HIV-1C Strains Using an in-house Phenotypic Assay and Commonly Used Genotypic Methods
Journal: Current HIV Research
Volume: 16 Issue: 2 Year: 2018 Page: 113-120
Author(s): Amare Worku Kalu,Nigus Fikrie Telele,Shambhu G Aralaguppe,Solomon Gebre-Selassie,Daniel Fekade,Gaetano Marrone,Anders Sonnerborg
Identification and Validation of CCR5 Antagonists from Maraviroc Analogs by Pharmacophore Modelling and 3D-QSAR Studies
Journal: Current Drug Therapy
Volume: 9 Issue: 3 Year: 2014 Page: 188-198
Author(s): Sapam Tuleshwori Devi,Anushree Dutta,Bhagath Kumar Palaka,Mohd Babu Khan,Kasi Viswanath,Ampasala Dinakara Rao
Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment
Journal: Current HIV Research
Volume: 14 Issue: 1 Year: 2016 Page: 24-36
Author(s): Olga S. Latinovic,Jian Zhang,Yutaka Tagaya,Anthony L. DeVico,Timothy R. Fouts,K. Schneider,Joseph R. Lakowicz,Alonso Heredia,Robert R. Redfield
Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes
Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2016 Page: 1091-1106
Author(s): Michael Roche, Katharina Borm, Jacqueline K. Flynn, Sharon R. Lewin, Melissa J. Churchill, Paul R. Gorry
HIV-1 Entry Inhibitors
Ebook: Frontiers in HIV Research
Volume: 1 Year: 2015
Author(s): Joshua R. Sawyer,Charles S. Venuto,Gene D. Morse
Doi: 10.2174/9781681080567115010006
Targeting the HIV-1 Tat and Human Tat Protein Complex through NaturalProducts: An In Silico Docking and Molecular Dynamics SimulationApproach
Journal: Letters in Drug Design & Discovery
Volume: 19 Issue: 11 Year: 2022 Page: 982-995
Author(s): Vinay Kumar Singh